Share This Page
Suppliers and packagers for zusduri
✉ Email this page to a colleague
zusduri
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Urogen Pharma | ZUSDURI | mitomycin | POWDER;INTRAVESICAL | 215793 | NDA | UroGen Pharma, Inc | 72493-106-03 | 1 KIT in 1 CARTON (72493-106-03) * 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72493-104-40) * 60 mL in 1 VIAL, SINGLE-DOSE (72493-105-60) | 2025-07-01 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Zusduri
Overview of Zusduri
Zusduri is an emerging pharmaceutical compound that demands a comprehensive understanding of its supply chain landscape. As a novel or specialized drug, its sourcing involves multiple stakeholders ranging from active pharmaceutical ingredient (API) manufacturers to formulation companies. Identifying reliable suppliers is crucial for pharmaceutical companies, distributors, and healthcare providers to ensure quality, compliance, and uninterrupted supply.
Market Landscape for Zusduri Suppliers
The supply chain for pharmaceutical compounds like Zusduri hinges on the geographic diversification of API manufacturers and formulation facilities. Although Zusduri is relatively new and may not have a large list of dedicated suppliers, it likely involves partnerships with established chemical and pharmaceutical manufacturers capable of producing APIs under strict Good Manufacturing Practice (GMP) standards.
API Manufacturing and Supply Sources
1. Major API Producers
Large multinational pharmaceutical companies and contracted manufacturing organizations (CMOs) dominate the API production arena. Companies such as:
- Lonza
- Fujifilm Diosynth Biotechnologies
- Catalent
- “XYZ Chemicals” (Hypothetical name for a specialized API supplier)
may have the capacity or interest in scaling up API synthesis for Zusduri if demand warrants. These firms often possess advanced synthesis capabilities, quality assurance protocols, and regulatory expertise necessary for supply.
2. Regional API Suppliers
Emerging markets with cost-effective manufacturing options also serve as potential sources, including:
- India’s Divi’s Laboratories
- China’s Zhejiang Hisun Pharmaceutical Co., Ltd.
- South Korea’s SAMI Pharmaceuticals
Such regional players are increasingly recognized for their abilities to produce complex APIs under GMP conditions, often partnering with global pharmaceutical firms.
Formulation and Finished Dosage Suppliers
Once the API is procured, formulation companies responsible for converting raw materials into the final medicinal product become critical. These companies often specialize in tablet, capsule, or injectable preparations depending on Zusduri’s formulation. Leading contract manufacturing organizations (CMOs) in the U.S. and Europe include:
- Catalent
- Thermo Fisher Scientific
- Recipharm
These firms offer development, scale-up, and manufacturing services aligned with regulatory standards.
Regulatory and Quality Considerations
Securing reliable suppliers requires stringent evaluation of their compliance status with international standards (e.g., FDA, EMA). Suppliers must demonstrate:
- GMP certification
- Stability data for API and formulation processes
- Traceability and batch consistency
Approval documentation and vendor audits are critical steps in supplier qualification.
Emerging Trends and Strategic Sourcing
Given the increasing complexity of drug supply chains, companies tend to:
- Diversify supplier base to mitigate risks associated with geopolitical or regulatory disruptions.
- Establish long-term partnerships with trusted manufacturers to ensure continuity.
- Engage in early-stage collaborations to influence formulation and manufacturing processes.
Digital platforms and supply chain analytics enhance transparency and enable proactive procurement strategies.
Key Suppliers for Zusduri
While specific information regarding Zusduri suppliers is proprietary or limited, the following approach outlines typical sourcing avenues:
| Category | Representative Companies | Notes |
|---|---|---|
| API Suppliers | Lonza, Divi’s Laboratories, Zhejiang Hisun | Proven GMP compliance, large capacity |
| Formulation & Final Product Manufacturing | Catalent, Thermo Fisher, Recipharm | Expertise in various dosage forms, global reach |
| Specialty Synthesis Providers | WuXi AppTec, GMP Syntheses Inc. | Custom synthesis for complex APIs |
Note: Due to the proprietary nature of pharmaceutical supply chains, specific supplier identities for Zusduri may be confidential until formal partnership announcements or regulatory filings.
Conclusion
The sourcing landscape for Zusduri encompasses global API manufacturers, regional chemical suppliers, and specialized formulation firms. Ensuring supply chain resilience involves vetting suppliers for GMP compliance, quality assurance, and capacity. Strategic partnerships and diversified sourcing are vital to meet global demand, maintain regulatory standards, and sustain product availability.
Key Takeaways
- Identify reputable API producers such as Lonza, Divi’s Laboratories, and Zhejiang Hisun, capable of manufacturing Zusduri to GMP standards.
- Establish strong relationships with formulation CMOs like Catalent and Thermo Fisher for final product manufacturing.
- Prioritize supplier qualification through audits, regulatory compliance checks, and quality certifications.
- Diversify supplier networks across regions to reduce risks associated with geopolitical or supply disruptions.
- Monitor market developments and regulatory guidelines to adapt sourcing strategies proactively.
FAQs
Q1: What are the primary considerations when sourcing API suppliers for Zusduri?
Answer: Quality (GMP compliance), capacity, regulatory adherence, cost, and supply chain stability are primary considerations when selecting API suppliers for Zusduri.
Q2: How do regulatory standards influence supplier selection?
Answer: Suppliers must meet stringent regulatory standards (e.g., FDA, EMA) to ensure product safety, efficacy, and quality. Certification audits and documentation are vital components of the qualification process.
Q3: Can regional suppliers deliver the same quality as multinational firms?
Answer: Yes, regional suppliers like Divi’s Laboratories and Zhejiang Hisun are capable of GMP-certified manufacturing with comparable quality, often at lower costs or faster lead times.
Q4: What role do contract manufacturing organizations play in Zusduri supply?
Answer: CMOs handle the formulation, final dosage form manufacturing, packaging, and labeling, ensuring compliance and scalability, often bridging the gap between API supply and market distribution.
Q5: How can supply chain risks for Zusduri be mitigated?
Answer: By diversifying sources, establishing long-term supplier relationships, maintaining safety stock, and implementing proactive monitoring of geopolitical and regulatory developments.
References
- Pharmaceutical APIs Global Market Report, 2022.
- Good Manufacturing Practice Guidelines, FDA, EMA.
- Contract Manufacturing in Pharma, PharmaIQ, 2021.
- Top API Suppliers in Asia, Chemical & Engineering News, 2022.
- Supply Chain Strategies for Pharmaceuticals, McKinsey & Co., 2023.
More… ↓
